Arbutus Biopharma Corp Increase (Decrease) in Other Operating Liabilities
Arbutus Biopharma Corp (ABUS) reported Increase (Decrease) in Other Operating Liabilities of -$218.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2026-08-12
- Arbutus Biopharma Corp increase (decrease) in other operating liabilities for the quarter ending 2026-06-30 was -$113.00K.
- Arbutus Biopharma Corp increase (decrease) in other operating liabilities for the quarter ending 2026-03-31 was -$105.00K.
- Arbutus Biopharma Corp increase (decrease) in other operating liabilities for the quarter ending 2025-12-31 was -$177.00K.
- Arbutus Biopharma Corp increase (decrease) in other operating liabilities for the quarter ending 2025-09-30 was -$155.00K.
- Arbutus Biopharma Corp increase (decrease) in other operating liabilities for fiscal 2025 was -$557.00K.
- Arbutus Biopharma Corp increase (decrease) in other operating liabilities for fiscal 2024 was -$430.00K.
- Arbutus Biopharma Corp increase (decrease) in other operating liabilities for fiscal 2023 was -$444.00K.
- Arbutus Biopharma Corp increase (decrease) in other operating liabilities for fiscal 2022 was -$405.00K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 6 month as first filed | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month | Increase (Decrease) in Other Operating Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$113.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$218.00K 10-Q · filed 2026-08-12 | -$395.00K derived: sum of 3 quarters · filed 2026-08-12 | -$550.00K derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2026-03-31 | -$105.00K 10-Q · filed 2026-05-13 | -$282.00K derived: sum of 2 quarters · filed 2026-05-13 | -$437.00K derived: sum of 3 quarters · filed 2026-05-13 | -$558.00K derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-12-31 | -$177.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$332.00K derived: sum of 2 quarters · filed 2026-03-23 | -$453.00K derived: sum of 3 quarters · filed 2026-08-12 | -$557.00K 10-K · filed 2026-03-23 | ||
| 2025-09-30 | -$155.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$276.00K derived: sum of 2 quarters · filed 2026-08-12 | -$380.00K 10-Q · filed 2025-11-13 | -$504.00K derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-06-30 | -$121.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$225.00K 10-Q · filed 2026-08-12 | -$349.00K derived: sum of 3 quarters · filed 2026-08-12 | -$505.00K derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-03-31 | -$104.00K 10-Q · filed 2026-05-13 | -$228.00K derived: sum of 2 quarters · filed 2026-05-13 | -$384.00K derived: sum of 3 quarters · filed 2026-05-13 | -$462.00K derived: sum of 4 quarters · filed 2026-05-13 | ||
| 2024-12-31 | -$124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$280.00K derived: sum of 2 quarters · filed 2026-03-23 | -$358.00K derived: sum of 3 quarters · filed 2026-03-23 | -$430.00K 10-K · filed 2026-03-23 | ||
| 2024-09-30 | -$156.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$234.00K derived: sum of 2 quarters · filed 2025-11-13 | -$306.00K 10-Q · filed 2025-11-13 | -$461.00K derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | -$78.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$150.00K 10-Q · filed 2025-08-06 | -$305.00K derived: sum of 3 quarters · filed 2025-08-06 | -$447.00K derived: sum of 4 quarters · filed 2025-08-06 | ||
| 2024-03-31 | -$72.00K 10-Q · filed 2025-05-14 | -$227.00K derived: sum of 2 quarters · filed 2025-05-14 | -$369.00K derived: sum of 3 quarters · filed 2025-05-14 | -$442.00K derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | -$155.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$297.00K derived: sum of 2 quarters · filed 2025-03-27 | -$370.00K derived: sum of 3 quarters · filed 2025-03-27 | -$444.00K 10-K · filed 2025-03-27 | ||
| 2023-09-30 | -$142.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$215.00K derived: sum of 2 quarters · filed 2024-11-06 | -$289.00K 10-Q · filed 2024-11-06 | -$413.00K derived: sum of 4 quarters · filed 2024-11-06 | ||
| 2023-06-30 | -$73.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$147.00K 10-Q · filed 2024-08-08 | -$271.00K derived: sum of 3 quarters · filed 2024-08-08 | -$403.00K derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | -$74.00K 10-Q · filed 2024-05-02 | -$198.00K derived: sum of 2 quarters · filed 2024-05-02 | -$330.00K derived: sum of 3 quarters · filed 2024-05-02 | -$404.00K derived: sum of 4 quarters · filed 2024-05-02 | ||
| 2022-12-31 | -$124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -$256.00K derived: sum of 2 quarters · filed 2024-03-05 | -$330.00K derived: sum of 3 quarters · filed 2024-03-05 | -$405.00K 10-K · filed 2024-03-05 | ||
| 2022-09-30 | -$132.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$206.00K derived: sum of 2 quarters · filed 2023-11-07 | -$281.00K 10-Q · filed 2023-11-07 | -$412.00K derived: sum of 4 quarters · filed 2023-11-07 | ||
| 2022-06-30 | -$74.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$149.00K 10-Q · filed 2023-08-03 | -$280.00K derived: sum of 3 quarters · filed 2023-08-03 | -$405.00K derived: sum of 4 quarters · filed 2023-08-03 | ||
| 2022-03-31 | -$75.00K 10-Q · filed 2023-05-04 | -$206.00K derived: sum of 2 quarters · filed 2023-05-04 | -$331.00K derived: sum of 3 quarters · filed 2023-05-04 | -$333.00K derived: sum of 4 quarters · filed 2023-05-04 | ||
| 2021-12-31 | -$131.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | -$256.00K derived: sum of 2 quarters · filed 2023-03-02 | -$258.00K derived: sum of 3 quarters · filed 2023-03-02 | -$374.00K 10-K · filed 2023-03-02 | -$369.00K 10-K · filed 2022-03-03 | |
| 2021-09-30 | -$125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$127.00K derived: sum of 2 quarters · filed 2022-11-09 | -$243.00K 10-Q · filed 2022-11-09 | -$333.00K derived: sum of 4 quarters · filed 2022-11-09 | ||
| 2021-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$118.00K 10-Q · filed 2022-08-04 | -$208.00K derived: sum of 3 quarters · filed 2022-08-04 | -$342.00K derived: sum of 4 quarters · filed 2022-08-04 | ||
| 2021-03-31 | -$116.00K 10-Q · filed 2022-05-05 | -$206.00K derived: sum of 2 quarters · filed 2022-05-05 | -$340.00K derived: sum of 3 quarters · filed 2022-05-05 | -$360.00K derived: sum of 4 quarters · filed 2022-05-05 | ||
| 2020-12-31 | -$90.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | -$224.00K derived: sum of 2 quarters · filed 2022-03-03 | -$244.00K derived: sum of 3 quarters · filed 2022-03-03 | -$375.00K 10-K · filed 2022-03-03 | ||
| 2020-09-30 | -$134.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$154.00K derived: sum of 2 quarters · filed 2021-11-04 | -$285.00K 10-Q · filed 2021-11-04 | -$488.00K derived: sum of 4 quarters · filed 2021-11-04 | ||
| 2020-06-30 | -$20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$151.00K 10-Q · filed 2021-08-05 | -$354.00K derived: sum of 3 quarters · filed 2021-08-05 | -$800.00K derived: sum of 4 quarters · filed 2021-08-05 | ||
| 2020-03-31 | -$131.00K 10-Q · filed 2021-05-05 | -$334.00K derived: sum of 2 quarters · filed 2021-05-05 | -$780.00K derived: sum of 3 quarters · filed 2021-05-05 | -$788.00K derived: sum of 4 quarters · filed 2021-05-05 | ||
| 2019-12-31 | -$203.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | -$649.00K derived: sum of 2 quarters · filed 2021-03-04 | -$657.00K derived: sum of 3 quarters · filed 2021-03-04 | -$744.00K 10-K · filed 2021-03-04 | -$665.00K 10-K · filed 2020-03-05 | |
| 2019-09-30 | -$446.00K 10-Q · filed 2019-11-06 | -$454.00K derived: sum of 2 quarters · filed 2019-11-06 | -$541.00K 10-Q · filed 2020-11-05 | -$539.00K derived: sum of 4 quarters · filed 2020-05-11 | ||
| 2019-06-30 | -$8.00K 10-Q · filed 2019-08-05 | $423.00K 10-Q · filed 2020-08-07 | -$95.00K 10-Q · filed 2019-08-05 | -$93.00K derived: sum of 3 quarters · filed 2020-05-11 | -$93.00K derived: sum of 4 quarters · filed 2020-05-11 | |
| 2019-03-31 | -$87.00K 10-Q · filed 2020-05-11 | -$85.00K derived: sum of 2 quarters · filed 2020-05-11 | -$85.00K derived: sum of 3 quarters · filed 2020-05-11 | -$85.00K derived: sum of 4 quarters · filed 2020-05-11 | ||
| 2018-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $2.00K derived: sum of 2 quarters · filed 2020-03-05 | $2.00K derived: sum of 3 quarters · filed 2020-03-05 | $0.00 10-K · filed 2020-03-05 | ||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-06 | $0.00 derived: sum of 2 quarters · filed 2019-11-06 | -$2.00K 10-Q · filed 2019-11-06 | |||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-05 | $0.00 10-Q · filed 2019-08-05 | ||||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |